Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Psychosis

Interventions

DRUG

Levetiracetam

Single dose of 500mg levetiracetam The capsules of levetiracetam and placebo will be visibly the same.

DRUG

Placebo

Single dose of 75mg ascorbic acid. The capsules of levetiracetam and placebo will be visibly the same.

Trial Locations (1)

RECRUITING

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London

All Listed Sponsors

lead

King's College London

OTHER